GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bal Pharma Ltd (NSE:BALPHARMA) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Bal Pharma (NSE:BALPHARMA) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 19, 2025)


View and export this data going back to 2006. Start your Free Trial

What is Bal Pharma Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Bal Pharma's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of Bal Pharma's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Bal Pharma's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bal Pharma's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bal Pharma's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Bal Pharma's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

Bal Pharma  (NSE:BALPHARMA) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Bal Pharma Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Bal Pharma's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Bal Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bal Pharma Ltd (NSE:BALPHARMA) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
BOM:524518 BOM:531173 NSE:VAISHALI BOM:524412 BOM:524828 BOM:524202 BOM:532989 BOM:530233 BOM:532384 BOM:530313 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
524824:India
Address
10/1, Palace Road, 5th Floor, Lakshmi Narayan Complex, Bengaluru, KA, IND, 560052
Website
https://www.balpharma.com
Bal Pharma Ltd is a pharmaceutical company. It is principally engaged in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients. The company specializes in prescription drugs, generic and over-the-counter products, intravenous infusion, and bulk actives. It offers products in dosage forms, such as tablets, capsules, syrups, suspensions, creams, and ointments, to various markets.

Bal Pharma Headlines

No Headlines